The use of ablative radiation therapy (A-RT) led to promising overall survival and effective local tumor control in patients ...

Verastem, Inc.'s priority PDUFA date for avutometinib + defactinib in LGSOC set for June 2025; explore future data updates.

A laboratory on Long Island has found a breakthrough in the fight against pancreatic cancer that can “intercept” its spread.

Researchers at the Cold Spring Harbor Laboratory have found a way to slow the progression of pancreatic cancer during its ...

Pancreatic ductal adenocarcinom a (PDAC), frequently detected at advanced stages, has a 5-year survival rate of 12%. Metastases are common, including hepatic metastasis, which is particularly lethal ...

The world-class pancreatic cancer researcher at Johns Hopkins University had so-called indirect funds slashed by the federal ...

City of Hope researchers demonstrate proof of concept for a novel targeted therapy for pancreatic cancer, exploiting ...

Researchers at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S.

A new study focused on transcription-replication conflicts, which occur when mechanisms responsible for gene expression and ...

Researchers have identified a new molecular target for treating pancreatic cancer. Scientists focused on transcription-replication conflicts (TRCs), which occur when the mechanisms responsible for ...

Researchers at City of Hope have identified a new molecular target for treating pancreatic cancer, reports a Gastroenterology ...